Brief: Mankind Pharma Q1 Consol Net Profit 4.38 Billion Rupees
31/07/2025 13:03
July 31 (Reuters) - Mankind Pharma Ltd MNKI.NS: MANKIND PHARMA Q1 CONSOL NET PROFIT 4.38 BILLION RUPEES MANKIND PHARMA Q1 CONSOL REVENUE FROM OPERATIONS 35.7 BILLION RUPEES TO RAISE SHORT TERM FUNDS VIA FUNDING INSTRUMENTS UPTO 10 BILLION RUPEES APPROVED ACQUISITION OF BRANDED GENERIC BUSINESS RELATING TO WOMEN HEALTH RX PORTFOLIO Source text: [ID:] Further company coverage: MNKI.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mankind Pharma
See all newsIndia's Mankind Pharma heads for best day in over 3 years as Q2 hints at recovery
Mankind Pharma's quarterly profit jumps 39% on strong chronic drug demand
India's Mankind Pharma gains on higher quarterly profit
Brief: Mankind Pharma Says To Buy 70% Majority Stake In Armed Cell Therapeutics Through Unit
Kotak upgrades India's Mankind Pharma to 'buy' on signs of business recovery